An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Regional Cancer Care Associates LLC

Clinical Trials

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Type of Cancer
Solid Tumor
Locations
Bethesda
Sponsor
Ignyta, Inc.
Protocol Number
RXDX-101-02
Cancer Diagnosis
To Learn More Call
201-510-0910